References for this Review were identified by searches of MEDLINE until April 2006 with the terms “chorea”, “Huntington's disease”, “Sydenham's chorea”, “PANDAS”, “hemiballism”, and “drug-induced chorea”. References were also selected from relevant articles and chapters of recent books on movement disorders. Only papers published in English were included
ReviewSeminar on choreas
Introduction
The term “chorea” entered medical writings through descriptions of religiously inspired outbreaks of mass hysteria in the middle ages—coincident with outbreaks of the plague in central Europe—when pilgrims engaged in ecstatic jumping or dancing movements for hours on end to the point of delirium and exhaustion.1 These rituals were associated with various saints the worshippers called on, of whom Saint Vitus became the most widely known, and “Saint Vitus Dance” persisted as a synonymous term for chorea in 20th century textbooks of neurology. Paracelsus was probably the first to make a distinction between “chorea naturalis” (a true organic medical disorder) and non-organic forms, which he classified into “chorea imaginativa” and “chorea lasciva”.2 Thomas Sydenham further developed the concept of organic causes of chorea in the late 17th century with his description of childhood chorea.3 The association between Sydenham's chorea, rheumatic fever, and endocarditis, however, was not appreciated before the 19th century, by which time there was also clear recognition of hereditary chorea through the concise report by George Huntington on affected families in the state of New York.4 Today, chorea is recognised as one of the major categories of movement disorders caused by dysfunctional neuronal networks connecting the basal ganglia and motor cortical areas. Choreas can be associated with a plethora of different causes.
Section snippets
Definition and clinical phenotype
Chorea is defined as a syndrome characterised by abrupt involuntary movements resulting from a continuous flow of random muscle contractions. The pattern of movement can sometimes seem playful and convey a feeling of restlessness to the observer. When choreic movements are more severe, assuming a flinging, sometimes violent, character, they are called ballism. Regardless of its cause, chorea has the same features. The differential diagnosis of choreic syndromes relies not so much on differences
Neuroanatomy and neurophysiology of chorea
Chorea results from dysfunction within a complex neuronal network interconnecting motor cortical areas and a group of subcortical nuclei collectively termed the basal ganglia. The latter include the caudate nucleus, putamen, external and internal segments of the globus pallidus (GPe and GPi) as well as associated structures such as the subthalamic nucleus and the substantia nigra (figure 1).
Over the past 15 years, there has been substantial progress in understanding how these corticosubcortical
Aetiological classification of choreas
The neurophysiological imbalance causing chorea can result from many diverse causes including infections, autoimmune disease, genetic mutations, neurodegeneration, stroke, neoplasms, drug-exposure, and metabolic diseases (panel 1).
Diagnostic work-up
Clinical differential diagnosis is guided by age at onset, family and drug histories, associated non-choreic symptoms, course of illness, and ancillary tests (figure 4).
Principles of management
Therapeutic management of chorea should aim to remove the cause and this can be successful in drug-induced chorea, metabolic or endocrine choreas, and to some extent even in autoimmune choreas like Sydenham's chorea with penicillin prophylaxis. Preventive strategies come into play in genetic choreas like Huntington's disease, where careful genetic counselling of affected patients and their relatives is needed. In most choreic syndromes seen in clinical practice, causal therapies are not
Conclusion
Although easily diagnosed as a syndrome based on a characteristic and distinctive pattern of involuntary movements, the differential diagnosis of chorea is complex, including genetic neurodegenerative diseases like Huntington's disease, autoimmune processes targeting the basal ganglia like Sydenham's chorea, structural basal ganglia lesions, or various drug-induced, toxic, or metabolic insults to basal ganglia–cortical networks. A carefully taken history will give clues to common causes like
Search strategies and selection criteria
References (159)
- et al.
The functional anatomy of basal ganglia disorders
Trends Neurosci
(1989) Primate models of movement disorders of basal ganglia origin
Trends Neurosci
(1990)- et al.
Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease
Neurosci Lett
(1991) - et al.
Neuropsychiatry of Huntington's disease and other basal ganglia disorders
Psychosomatics
(2000) - et al.
Neuroacanthocytosis: new developments in a neglected group of dementing disorders
J Neurol Sci
(2005) - et al.
Huntington disease phenocopy is a familial prion disease
Am J Hum Genet
(2001) - et al.
Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens
Brain Dev
(2002) - et al.
[Chorea-athetosis in the anti-Hu syndrome]
Rev Neurol (Paris)
(2004) - et al.
Hemichorea: a rare presentation of tuberculoma
J Neurol Sci
(2003) - et al.
Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study
Lancet Neurol
(2005)
History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000
Mov Disord
Schedula monitoria de novae febris ingressu
On chorea
The Medical and Surgical Reporter: A Weekly Journal
The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns
Arch Neurol
The basal ganglia and disorders of movement: pathophysiological mechanisms
News Physiol Sci
Bilateral globus pallidus stimulation for Huntington's disease
Ann Neurol
Selective sparing of a class of striatal neurons in Huntington's disease
Science
Diagnosis of Huntington disease
Clin Chem
Huntington disease in Maryland: clinical aspects of racial variation
Am J Hum Genet
Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study
Eur J Hum Genet
Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing
J Neurol Neurosurg Psychiatry
High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia
Clin Genet
Huntington's chorea on the island of Mauritius
S Afr Med J
Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989)
Arch Neurol
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
Cell
Huntington's Disease
Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats
Am J Hum Genet
Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease
Am J Hum Genet
DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland
Neurology
Trinucleotide repeat length instability and age of onset in Huntington's disease
Nat Genet
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
Nat Genet
Abnormal ocular motor control in Huntington's disease
Neurology
Adult onset myoclonic Huntington's disease
Mov Disord
Tourettism associated with Huntington's disease
Mov Disord
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome
J Neurol Neurosurg Psychiatry
Bruxism in Huntington's disease
Mov Disord
Psychiatric syndromes in Huntington's disease
Am J Psychiatry
Huntington's disease: update and review of neuropsychiatric aspects
Int J Psychiatry Med
Increased rate of suicide among patients with Huntington's disease
J Neurol Neurosurg Psychiatry
Psychopathology in Huntington's disease patients
Acta Psychiatr Scand
Clinical management of aggression and frontal syndromes in Huntington's disease
Clinical management of psychosis and mood disorders in Huntington's disease
Profile of cognitive progression in early Huntington's disease
Neurology
Executive and mnemonic functions in early Huntington's disease
Brain
Progression of symptoms in the early and middle stages of Huntington disease
Arch Neurol
Clinical features and treatment of Huntington's disease
Causes of death in patients with Huntington's disease and in unaffected first degree relatives
J Med Genet
Conditions associated with Huntington's disease at death. A case-control study
Arch Neurol
Huntington's disease: present treatments and future therapeutic modalities
Int Clin Psychopharmacol
Cited by (240)
Before Hemichorea Can Be Attributed to Diabetic Striatopathy, All Other Causes Must Be Thoroughly Ruled Out
2024, Journal of Emergency MedicineTechnologies for the management of hyperkinetic movement disorders
2024, Handbook of Digital Technologies in Movement DisordersNonketotic Hyperglycemic Hemichorea in an Elderly Male: A Case Report
2023, Journal of Emergency MedicineValbenazine as treatment for Huntington's disease chorea
2023, The Lancet NeurologyAltered brain connectivity in hyperkinetic movement disorders: A review of resting-state fMRI
2023, NeuroImage: ClinicalTremor and abnormal involuntary movement of the hand
2023, Revue du Rhumatisme (Edition Francaise)